English
简体中文
Total: £ 56.28
Published Date: 2024-04-07 | Pages: 129 | Tables: 247 | Pharma & Healthcare
Choroideremia is an X-linked chorioretinal dystrophy characterized by the diffuse, progressive degeneration of the retinal pigment epithelium (RPE), photoreceptors and choriocapillaris. It is caused by a mutation in the CHM gene and is the focus of exciting basic and clinical research.
The global market for Choroideremia Treatment was estimated to be worth US$ 3340 million in 2023 and is forecast to a readjusted size of US$ 4690.3 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Choroideremia Treatment, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Choroideremia Treatment by region & country, by Type, and by Application.
The Choroideremia Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Choroideremia Treatment.
Market Segmentation
By Company
Novartis AG
Spark Therapeutics
Bluebird Bio Inc.
Biogen
Copernicus Therapeutics, Inc.
4D Molecular Therapeutics
Wize Pharma Inc.
Retina Implant AG
Hoffmann-La Roche Ltd
Pixium Vision
Merck
Teva
Segment by Type:
Oral
Intravenous
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Choroideremia Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Choroideremia Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Choroideremia Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Choroideremia Treatment Product Introduction
1.2 Global Choroideremia Treatment Market Size Forecast
1.2.1 Global Choroideremia Treatment Sales Value (2019-2030)
1.2.2 Global Choroideremia Treatment Sales Volume (2019-2030)
1.2.3 Global Choroideremia Treatment Sales Price (2019-2030)
1.3 Choroideremia Treatment Market Trends & Drivers
1.3.1 Choroideremia Treatment Industry Trends
1.3.2 Choroideremia Treatment Market Drivers & Opportunity
1.3.3 Choroideremia Treatment Market Challenges
1.3.4 Choroideremia Treatment Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Choroideremia Treatment Players Revenue Ranking (2023)
2.2 Global Choroideremia Treatment Revenue by Company (2019-2024)
2.3 Global Choroideremia Treatment Players Sales Volume Ranking (2023)
2.4 Global Choroideremia Treatment Sales Volume by Company Players (2019-2024)
2.5 Global Choroideremia Treatment Average Price by Company (2019-2024)
2.6 Key Manufacturers Choroideremia Treatment Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Choroideremia Treatment Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Choroideremia Treatment
2.9 Choroideremia Treatment Market Competitive Analysis
2.9.1 Choroideremia Treatment Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Choroideremia Treatment Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroideremia Treatment as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Intravenous
3.2 Global Choroideremia Treatment Sales Value by Type
3.2.1 Global Choroideremia Treatment Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Choroideremia Treatment Sales Value, by Type (2019-2030)
3.2.3 Global Choroideremia Treatment Sales Value, by Type (%) (2019-2030)
3.3 Global Choroideremia Treatment Sales Volume by Type
3.3.1 Global Choroideremia Treatment Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Choroideremia Treatment Sales Volume, by Type (2019-2030)
3.3.3 Global Choroideremia Treatment Sales Volume, by Type (%) (2019-2030)
3.4 Global Choroideremia Treatment Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Choroideremia Treatment Sales Value by Application
4.2.1 Global Choroideremia Treatment Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Choroideremia Treatment Sales Value, by Application (2019-2030)
4.2.3 Global Choroideremia Treatment Sales Value, by Application (%) (2019-2030)
4.3 Global Choroideremia Treatment Sales Volume by Application
4.3.1 Global Choroideremia Treatment Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Choroideremia Treatment Sales Volume, by Application (2019-2030)
4.3.3 Global Choroideremia Treatment Sales Volume, by Application (%) (2019-2030)
4.4 Global Choroideremia Treatment Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Choroideremia Treatment Sales Value by Region
5.1.1 Global Choroideremia Treatment Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Choroideremia Treatment Sales Value by Region (2019-2024)
5.1.3 Global Choroideremia Treatment Sales Value by Region (2025-2030)
5.1.4 Global Choroideremia Treatment Sales Value by Region (%), (2019-2030)
5.2 Global Choroideremia Treatment Sales Volume by Region
5.2.1 Global Choroideremia Treatment Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Choroideremia Treatment Sales Volume by Region (2019-2024)
5.2.3 Global Choroideremia Treatment Sales Volume by Region (2025-2030)
5.2.4 Global Choroideremia Treatment Sales Volume by Region (%), (2019-2030)
5.3 Global Choroideremia Treatment Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Choroideremia Treatment Sales Value, 2019-2030
5.4.2 North America Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Choroideremia Treatment Sales Value, 2019-2030
5.5.2 Europe Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Choroideremia Treatment Sales Value, 2019-2030
5.6.2 Asia Pacific Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Choroideremia Treatment Sales Value, 2019-2030
5.7.2 South America Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Choroideremia Treatment Sales Value, 2019-2030
5.8.2 Middle East & Africa Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Choroideremia Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Choroideremia Treatment Sales Value
6.2.1 Key Countries/Regions Choroideremia Treatment Sales Value, 2019-2030
6.2.2 Key Countries/Regions Choroideremia Treatment Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Choroideremia Treatment Sales Value, 2019-2030
6.3.2 United States Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Choroideremia Treatment Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Choroideremia Treatment Sales Value, 2019-2030
6.4.2 Europe Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Choroideremia Treatment Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Choroideremia Treatment Sales Value, 2019-2030
6.5.2 China Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.5.3 China Choroideremia Treatment Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Choroideremia Treatment Sales Value, 2019-2030
6.6.2 Japan Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Choroideremia Treatment Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Choroideremia Treatment Sales Value, 2019-2030
6.7.2 South Korea Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Choroideremia Treatment Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Choroideremia Treatment Sales Value, 2019-2030
6.8.2 Southeast Asia Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Choroideremia Treatment Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Choroideremia Treatment Sales Value, 2019-2030
6.9.2 India Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
6.9.3 India Choroideremia Treatment Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Information
7.1.2 Novartis AG Introduction and Business Overview
7.1.3 Novartis AG Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Novartis AG Choroideremia Treatment Product Offerings
7.1.5 Novartis AG Recent Development
7.2 Spark Therapeutics
7.2.1 Spark Therapeutics Company Information
7.2.2 Spark Therapeutics Introduction and Business Overview
7.2.3 Spark Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Spark Therapeutics Choroideremia Treatment Product Offerings
7.2.5 Spark Therapeutics Recent Development
7.3 Bluebird Bio Inc.
7.3.1 Bluebird Bio Inc. Company Information
7.3.2 Bluebird Bio Inc. Introduction and Business Overview
7.3.3 Bluebird Bio Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bluebird Bio Inc. Choroideremia Treatment Product Offerings
7.3.5 Bluebird Bio Inc. Recent Development
7.4 Biogen
7.4.1 Biogen Company Information
7.4.2 Biogen Introduction and Business Overview
7.4.3 Biogen Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biogen Choroideremia Treatment Product Offerings
7.4.5 Biogen Recent Development
7.5 Copernicus Therapeutics, Inc.
7.5.1 Copernicus Therapeutics, Inc. Company Information
7.5.2 Copernicus Therapeutics, Inc. Introduction and Business Overview
7.5.3 Copernicus Therapeutics, Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Copernicus Therapeutics, Inc. Choroideremia Treatment Product Offerings
7.5.5 Copernicus Therapeutics, Inc. Recent Development
7.6 4D Molecular Therapeutics
7.6.1 4D Molecular Therapeutics Company Information
7.6.2 4D Molecular Therapeutics Introduction and Business Overview
7.6.3 4D Molecular Therapeutics Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.6.4 4D Molecular Therapeutics Choroideremia Treatment Product Offerings
7.6.5 4D Molecular Therapeutics Recent Development
7.7 Wize Pharma Inc.
7.7.1 Wize Pharma Inc. Company Information
7.7.2 Wize Pharma Inc. Introduction and Business Overview
7.7.3 Wize Pharma Inc. Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Wize Pharma Inc. Choroideremia Treatment Product Offerings
7.7.5 Wize Pharma Inc. Recent Development
7.8 Retina Implant AG
7.8.1 Retina Implant AG Company Information
7.8.2 Retina Implant AG Introduction and Business Overview
7.8.3 Retina Implant AG Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Retina Implant AG Choroideremia Treatment Product Offerings
7.8.5 Retina Implant AG Recent Development
7.9 Hoffmann-La Roche Ltd
7.9.1 Hoffmann-La Roche Ltd Company Information
7.9.2 Hoffmann-La Roche Ltd Introduction and Business Overview
7.9.3 Hoffmann-La Roche Ltd Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Hoffmann-La Roche Ltd Choroideremia Treatment Product Offerings
7.9.5 Hoffmann-La Roche Ltd Recent Development
7.10 Pixium Vision
7.10.1 Pixium Vision Company Information
7.10.2 Pixium Vision Introduction and Business Overview
7.10.3 Pixium Vision Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Pixium Vision Choroideremia Treatment Product Offerings
7.10.5 Pixium Vision Recent Development
7.11 Merck
7.11.1 Merck Company Information
7.11.2 Merck Introduction and Business Overview
7.11.3 Merck Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Merck Choroideremia Treatment Product Offerings
7.11.5 Merck Recent Development
7.12 Teva
7.12.1 Teva Company Information
7.12.2 Teva Introduction and Business Overview
7.12.3 Teva Choroideremia Treatment Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Teva Choroideremia Treatment Product Offerings
7.12.5 Teva Recent Development
8 Industry Chain Analysis
8.1 Choroideremia Treatment Industrial Chain
8.2 Choroideremia Treatment Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Choroideremia Treatment Sales Model
8.5.2 Sales Channel
8.5.3 Choroideremia Treatment Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Choroideremia Treatment Market Trends
Table 2. Choroideremia Treatment Market Drivers & Opportunity
Table 3. Choroideremia Treatment Market Challenges
Table 4. Choroideremia Treatment Market Restraints
Table 5. Global Choroideremia Treatment Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Choroideremia Treatment Revenue Market Share by Company (2019-2024)
Table 7. Global Choroideremia Treatment Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Choroideremia Treatment Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Choroideremia Treatment Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Choroideremia Treatment Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Choroideremia Treatment Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Choroideremia Treatment
Table 13. Global Choroideremia Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Choroideremia Treatment as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Choroideremia Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Choroideremia Treatment Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Choroideremia Treatment Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Choroideremia Treatment Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Choroideremia Treatment Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Choroideremia Treatment Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Choroideremia Treatment Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Choroideremia Treatment Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Choroideremia Treatment Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Choroideremia Treatment Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Choroideremia Treatment Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Choroideremia Treatment Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Choroideremia Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Choroideremia Treatment Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Choroideremia Treatment Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Choroideremia Treatment Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Choroideremia Treatment Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Choroideremia Treatment Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Choroideremia Treatment Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Choroideremia Treatment Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Choroideremia Treatment Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Choroideremia Treatment Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Choroideremia Treatment Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Choroideremia Treatment Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Choroideremia Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Choroideremia Treatment Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Choroideremia Treatment Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Choroideremia Treatment Sales Value by Region (2019-2024) & (%)
Table 44. Global Choroideremia Treatment Sales Value by Region (2025-2030) & (%)
Table 45. Global Choroideremia Treatment Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Choroideremia Treatment Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Choroideremia Treatment Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Choroideremia Treatment Sales Volume by Region (2019-2024) & (%)
Table 49. Global Choroideremia Treatment Sales Volume by Region (2025-2030) & (%)
Table 50. Global Choroideremia Treatment Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Choroideremia Treatment Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Choroideremia Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Choroideremia Treatment Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Choroideremia Treatment Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Choroideremia Treatment Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Choroideremia Treatment Sales Volume, (2025-2030) & (K Units)
Table 57. Novartis AG Company Information
Table 58. Novartis AG Introduction and Business Overview
Table 59. Novartis AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Novartis AG Choroideremia Treatment Product Offerings
Table 61. Novartis AG Recent Development
Table 62. Spark Therapeutics Company Information
Table 63. Spark Therapeutics Introduction and Business Overview
Table 64. Spark Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Spark Therapeutics Choroideremia Treatment Product Offerings
Table 66. Spark Therapeutics Recent Development
Table 67. Bluebird Bio Inc. Company Information
Table 68. Bluebird Bio Inc. Introduction and Business Overview
Table 69. Bluebird Bio Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Bluebird Bio Inc. Choroideremia Treatment Product Offerings
Table 71. Bluebird Bio Inc. Recent Development
Table 72. Biogen Company Information
Table 73. Biogen Introduction and Business Overview
Table 74. Biogen Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biogen Choroideremia Treatment Product Offerings
Table 76. Biogen Recent Development
Table 77. Copernicus Therapeutics, Inc. Company Information
Table 78. Copernicus Therapeutics, Inc. Introduction and Business Overview
Table 79. Copernicus Therapeutics, Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Copernicus Therapeutics, Inc. Choroideremia Treatment Product Offerings
Table 81. Copernicus Therapeutics, Inc. Recent Development
Table 82. 4D Molecular Therapeutics Company Information
Table 83. 4D Molecular Therapeutics Introduction and Business Overview
Table 84. 4D Molecular Therapeutics Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. 4D Molecular Therapeutics Choroideremia Treatment Product Offerings
Table 86. 4D Molecular Therapeutics Recent Development
Table 87. Wize Pharma Inc. Company Information
Table 88. Wize Pharma Inc. Introduction and Business Overview
Table 89. Wize Pharma Inc. Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Wize Pharma Inc. Choroideremia Treatment Product Offerings
Table 91. Wize Pharma Inc. Recent Development
Table 92. Retina Implant AG Company Information
Table 93. Retina Implant AG Introduction and Business Overview
Table 94. Retina Implant AG Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Retina Implant AG Choroideremia Treatment Product Offerings
Table 96. Retina Implant AG Recent Development
Table 97. Hoffmann-La Roche Ltd Company Information
Table 98. Hoffmann-La Roche Ltd Introduction and Business Overview
Table 99. Hoffmann-La Roche Ltd Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Hoffmann-La Roche Ltd Choroideremia Treatment Product Offerings
Table 101. Hoffmann-La Roche Ltd Recent Development
Table 102. Pixium Vision Company Information
Table 103. Pixium Vision Introduction and Business Overview
Table 104. Pixium Vision Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Pixium Vision Choroideremia Treatment Product Offerings
Table 106. Pixium Vision Recent Development
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Merck Choroideremia Treatment Product Offerings
Table 111. Merck Recent Development
Table 112. Teva Company Information
Table 113. Teva Introduction and Business Overview
Table 114. Teva Choroideremia Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Teva Choroideremia Treatment Product Offerings
Table 116. Teva Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. Choroideremia Treatment Downstream Customers
Table 120. Choroideremia Treatment Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Choroideremia Treatment Product Picture
Figure 2. Global Choroideremia Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Choroideremia Treatment Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Choroideremia Treatment Sales Volume (2019-2030) & (K Units)
Figure 5. Global Choroideremia Treatment Sales Price (2019-2030) & (US$/Unit)
Figure 6. Choroideremia Treatment Report Years Considered
Figure 7. Global Choroideremia Treatment Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Choroideremia Treatment Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Choroideremia Treatment Revenue in 2023
Figure 10. Choroideremia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Picture
Figure 12. Intravenous Picture
Figure 13. Global Choroideremia Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Choroideremia Treatment Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Choroideremia Treatment Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Choroideremia Treatment Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Choroideremia Treatment Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Hospital Pharmacies
Figure 19. Product Picture of Retail Pharmacies
Figure 20. Product Picture of Online Pharmacies
Figure 21. Global Choroideremia Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Choroideremia Treatment Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Choroideremia Treatment Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Choroideremia Treatment Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Choroideremia Treatment Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America Choroideremia Treatment Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Choroideremia Treatment Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Choroideremia Treatment Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Choroideremia Treatment Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Choroideremia Treatment Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Choroideremia Treatment Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Choroideremia Treatment Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Choroideremia Treatment Sales Volume (%), (2019-2030)
Figure 38. United States Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 44. China Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 46. China Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 56. India Choroideremia Treatment Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Choroideremia Treatment Sales Value by Type (%), 2023 VS 2030
Figure 58. India Choroideremia Treatment Sales Value by Application (%), 2023 VS 2030
Figure 59. Choroideremia Treatment Industrial Chain
Figure 60. Choroideremia Treatment Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
